Status: Recruiting
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment
Participants needed: 175
Trial details
Phase: Phase 1Age: 0-60Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Sep 4, 2025Locations: 1
Eligibility criteria
Child has had a prior nasal surveillance culture grow S. aurues [+4]
Child is a ward of the State [+14]